Canary Speech to Showcase AI-Powered Voice Biomarker Technology at HIMSS26 in the Microsoft Booth

Canary Speech will demonstrate clinically validated voice biomarkers as an extension to Dragon Copilot to enable scalable, responsible AI across health systems

Provo, UT - March 5, 2026 - Canary Speech, a leader in AI-driven voice biomarker technology, today announced it will be featured in the Microsoft booth (#2812) at HIMSS26, taking place March 9-12 at The Venetian Convention & Expo Center in Las Vegas. As a strategic healthcare partner within the Microsoft partner ecosystem, Canary Speech will demonstrate how its clinically validated voice analytics platform extends Dragon Copilot to deliver scalable, secure, and responsible AI solutions that transform patient care and operational performance.

At HIMSS26, Microsoft is highlighting how healthcare organizations can "Achieve more with AI you can trust," focusing on safeguarding health data, empowering the healthcare workforce, enhancing patient experiences, unlocking value from clinical and operational data, and accelerating research and discovery. Canary Speech's voice biomarker technology directly supports these priorities by transforming natural speech into objective, measurable insights that strengthen clinical decision-making and reduce system strain. The result is improved patient engagement, lower clinician burden, and actionable intelligence that drives measurable ROI across value-based care environments.

"Our partnership with Microsoft accelerates our ability to bring clinically actionable voice biomarkers to health systems in the US ," said Henry O'Connell, co-founder and CEO of Canary Speech. "Together, we are enabling healthcare organizations to move from reactive care models to proactive, AI-driven insights that improve outcomes while reducing cost."

Canary Speech's proprietary AI models analyze vocal characteristics to detect indicators of mild cognitive impairment, depression, anxiety, Parkinson's disease, and other health risks, without requiring additional hardware or workflow disruption. By partnering with Microsoft's Dragon Copilot, Canary Speech enables:

• Seamless ambient data capture to support documentation and care intelligence
• Real-time risk stratification for earlier intervention and improved outcomes
• Scalable deployment across health systems, telehealth platforms, and remote monitoring programs
• Enterprise-grade security and compliance, aligned with Microsoft's trusted AI framework

Canary Speech is listed among Microsoft's featured healthcare partners exhibiting within booth #2812, and will be available to meet with healthcare executives, digital health leaders, investors, and strategic partners interested in deploying voice AI at enterprise scale.

To schedule a meeting with Canary Speech during HIMSS26, please contact:
Caitlyn Brooksby
VP, Marketing
[email protected]

About Canary Speech:
Canary Speech is a Utah-based, AI-powered voice biomarker health tech company, utilizing patented real-time vocal analysis to screen for mental health and neurological disorders. Canary's technology swiftly captures and analyzes speech data, detecting behavioral and cognitive changes-including signs of anxiety, depression, and dementia-often before traditional clinical standards or noticeable symptoms. Recently, Canary Speech launched Canary Ambient™, an API-first solution for real-time voice analysis in healthcare and contact centers. This clinical decision support software provides actionable insights from patient-clinician conversations by tracking speech patterns for real-time assessments of cognitive and behavioral health conditions. Canary Speech advances speech and language applications across health systems, payers, and pharmaceutical markets.